Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
about
Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysisMarkers of physiological stress during exercise under conditions of normoxia, normobaric hypoxia, hypobaric hypoxia, and genuine high altitude.Late-life rapamycin treatment reverses age-related heart dysfunction.Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy.Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.Signaling in muscle contractionCardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.ANP-induced signaling cascade and its implications in renal pathophysiologyAberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Role of C-type natriuretic peptide in the function of normal human sperm.A role for natriuretic peptides in the central control of energy balance?Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseA Track Record on SHOX: From Basic Research to Complex Models and TherapyElevated systolic blood pressure in male GH transgenic mice is age dependent.Differences in the clinical and genotypic presentation of sickle cell disease around the world.Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.cGMP becomes a drug target.Clinical utility of novel biomarkers for cardiovascular disease risk stratification.MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides.Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist.Harnessing fetal and adult genetic reprograming for therapy of heart disease.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).Global left atrial failure in heart failure.Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization.Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.MAPK3/1 is conducive to luteinizing hormone-mediated C-type natriuretic peptide decrease in bovine granulosa cells.Short term variation in NTproBNP after lifestyle intervention in severe obesity.MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts.Changes of Atrial Natriuretic Peptides after Defibrillation Threshold Testing Predicted Future Ventricular Arrhythmia Event.Old tool - new application: NT-proBNP in fetal medicine.A rapid and cost-effective method of producing recombinant proBNP and NT-proBNP variants in Escherichia coli for immunoassay of heart failure.Pulmonary hypertension in hypertensive patients: association with diastolic dysfunction and increased pulmonary vascular resistance.Pro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites.Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.Gastric bypass surgery elevates NT-ProBNP levels.
P2860
Q26765883-92405D19-83DF-437D-9367-9267B05C3C2DQ26851289-544ADDF4-6414-4048-9B53-26EC9F3EBA20Q33555069-EC8A3459-D094-48E8-9020-F7E76142C8B9Q33903651-04474111-2FA1-4C4D-B5CC-A7349FF48C46Q34466688-25B6C32E-6E58-4384-B6A6-3D54DFD7BDC1Q34568189-69E6E9FE-9C0C-4573-B22E-04014BFB66DFQ35045136-4C73A9D4-90F2-4431-B96C-A71922A3A751Q35047672-9EE1D871-989D-479B-B87B-0D7AEDABD564Q35131225-9AB74B46-C566-44A1-987D-2DF97C7289C3Q35622455-187AD18B-8CC5-458B-9B41-C3327A57D7DAQ36046973-692212AE-F96B-4131-9D4B-BD3F4BDCF888Q36530262-460D4247-E7CC-4996-86C4-292B39E6FCAFQ36796083-6B1D260D-C993-4BCD-9954-48DB36EC9B94Q36932748-FF27C4AE-5A86-4E9D-8F09-5E353D80827DQ37147401-5C4C1E04-E1D2-403D-9563-D985EA3B7387Q37594091-0BCAB25E-3CE8-4884-BE9C-CA2FB137644EQ37620798-9416837D-F6F0-428B-9908-224C373A1178Q37873230-BA58FD3F-9517-467F-8756-52DFBDFF69A0Q37980254-B5D87BA2-98E4-415C-95AB-6A07B1DD7A10Q37980659-60863B61-4CCF-4692-A00A-F40F3B23D590Q38052852-3C21DB58-2E94-440D-9D27-D997EFAD2DDFQ38065253-115D636C-0627-4275-92E1-B966893E4050Q38120091-4CDFCBED-2991-455F-AC6D-3B0D5FCBACE6Q38423287-789C4F52-D9FC-435E-A52E-68BE2EE09580Q38546917-EC242CCB-2941-4907-B784-421C3D40EBDCQ38998559-8B36D74F-7A66-4180-8122-2A2C29E322DDQ39102349-AEE14373-AE68-46A3-A6A8-15A13C9C8AD7Q40584596-9216A169-A906-4C8C-95C5-37F35FD46878Q40738863-0C394516-5965-4352-BB6E-CFF376B72938Q41007414-220C6087-2149-4B3F-9DED-E2B5E93B1DB6Q41102306-8C2741F4-765B-482F-8AF4-C3B008495168Q42339382-37319818-62D6-4534-A33E-86199DCB99B2Q43968441-DAB7A33D-1B44-41D0-BF70-D753A6BF3A23Q44683095-9ABFE415-C4FC-43BD-B48D-901C6F15ADC1Q45398906-E7585ADC-72E5-4BB8-AA5D-F3D8E26C2087Q46706147-F0C2D758-7FD8-4361-A274-31FB2C3164ECQ47747440-DC4712C8-B3C8-446D-9620-C1BE9C2555C0Q47855200-B096E551-CD41-4D33-9159-D7B48881C045Q48005035-9CA425D2-F46E-495B-B52A-71E6D98870F0Q48141578-D77670FA-8232-493A-8627-A8BFCD50E908
P2860
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@en
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@nl
type
label
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@en
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@nl
prefLabel
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@en
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@nl
P2093
P1476
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
@en
P2093
Kazuwa Nakao
Koichiro Kuwahara
Toshio Nishikimi
P304
P356
10.1016/J.JJCC.2011.01.002
P577
2011-02-05T00:00:00Z